Technology

AddToAny

Google+ Facebook Twitter Twitter

New monotest system launched

Launch Diagnostics is pleased to introduce the new VIrClia monotest system, an indirect chemiluminescent immunoassay for the detection of antibodies against infectious diseases in human serum or plasma samples.

Each monotest contains wells for automatic sample addition plus the reagents necessary to perform the assay.  

Assays are automatically processed on the VirClia instrument with VirClia processing and interpretation software. 

The easy-to-use system supports bar code identification, use of primary sample tubes within the instrument racks and is completely versatile, enabling the custom set up of different assays in a single run. The Vircell portfolio includes infectious disease ELISAs and IFAs.  
launchdiagnostics.com

Related Articles

"HIV vaccine design shows promise"

A novel protein-sugar vaccine candidate has stimulated an immune response against sugars that form a protective shield around HIV.

Four decades of tuberculosis

Professor Douglas Young discusses the last 40 years of tuberculosis research, as he hangs up his lab coat for the final time.

Chemo-boosting Drug

Drugs developed to treat heart and blood vessel problems could be used in combination with chemot

Top